Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Financials up to date till end of June 2024. Imds is a shell .
Reverse merger with Bright new vision was to be completed by Dec31,2023.What is next?
Imo I think if we can time it right,we should be able to recoup.gltu
Are you still optimistic that we will recover some of our money or it’s dead.
Check out my posts re imds
Cant find much re Bright New Vision, relatively new.
https://icis.corp.delaware.gov/Ecorp/EntitySearch/NameSearch.aspx
Finally something happening.
https://www.sec.gov/Archives/edgar/data/790652/000121390023055591/ea181519ex99-1_imaging.htm
The purpose of this Letter of Intent (“LOI”) is to set forth the terms and conditions pursuant to which Imaging Diagnostics Systems, Inc., a Florida Corporation (“Imaging”) will enter into a business combination (the “Acquisition”) with Bright New Vision Inc., a Delaware corporation or its affiliate (“Company”).
Always hope.They continue to file financials and are up to date.no revenue yet.gltu
Is this completely dead or we still have hope.
Some changes at IMDS -new management and directors.Maybe something will happen one of these days.
https://docoh.com/filing/790652/0001213900-22-048692/IMDS-425
Yeah, and they can keep on doing it.relist,issue billions of shares, reverse split etc etc.
Sad how a company can take shareholders money without any penalties.
Have not seen anything to suggest that.Only time would be if this starts trading.
Anything new about the shareholders getting anything back?
Thank you I think the par value is .50
Thank you I think the par value is .50
Incorrect, these guys are filing, please see following;
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
[Mark One]
? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 31, 2021
or
? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____to______
Commission file number: 000-26028
IMAGING DIAGNOSTIC SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
Florida 22-2671269
(State of
Incorporation) (IRS Employer
Ident. No.)
618 E South St, Suite 500, Orlando, FL 32801
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number: (954) 581-9800
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes ? No ?
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes ? No ?
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non- accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ? Accelerated filer ? Smaller reporting company ?
Non-accelerated filer ? Emerging growth company ?
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ?
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.)
Yes ? No ?
The number of shares outstanding of the issuer’s common stock as of February 15, 2022: 123,156,941 shares of common stock, no par value.
It does not look like these guys are filling the Fins. This year.
Nothing yet.Have to wait for next financial filing, Q2 should be out sometime this month.gltu.
Anything new with IMDS?
Imo I'm very hopeful. IMDS is reporting timely and project to make some sales in China by end of 2022 year,which would be by June of 2022.I don't think it would take much to get this trading again once they get some revenue.good luck.
Any chance the shareholders going to recuperate any of their money any time soon?
Imaging Diagnostics 2022 1 st quarter fins out.
https://docoh.com/filing/790652/0001213900-21-057645/IMDS-10Q-2022Q1
Imds is actually better than most otc stocks.Currently waiting on year end fins which should be out by the end of this month.check out docoh.com/company/790652/IMDS
Anything new for us shareholders or just the company cheated everyone their hard earned money.
Just scanning thru,it appears that it may be 3 rd or 4th quarter 2021 the model 3.0 will start selling.Overall it looks good,but will be a while.gltu
Thank you...any hope for the shareholders?
Thanks...I hope so.
Annuals 10k came out last year the end of September,therefore we should see something soon.Perhaps we will get some information.
Any idea what happened here?
Rooster?
With what's going on with china do you think the company has dropped the idea of going public again?
Thanks oil
they stole everyone's hard earned money and ran.
Anybody know what is going on with imds????!!!!....
IMDS 10 Q out,ending Sept 30/19, right on schedule.
https://www.sec.gov/Archives/edgar/data/790652/000121390019023203/f10q0919_imagingdiagnostic.htm
Some highlights;The number of shares outstanding of the issuer’s common stock as of November 13, 2019: 122,758,901 shares of common stock
Sales revenues in China are not expected to begin until the second or third quarter of fiscal 2020
On November 4, 2019, the Company issued 137,255 shares of restricted common stock to a non-affiliated accredited investor pursuant to a Subscription Agreement for $70,000. The price per share was approximately $0.51 per share
My posts are sane and are based on the circumstances - and are generally asking anybody who is allowed to give a definitive answer as to if/when this stock will trade again???....So far been waiting and can't see a light at the end of the tunnel yet. I hope that all what has been and is being done will lead to this stock continuing to trade soon as the reverse stock split occured a while back!!!
Just some humor. Of course he's doing a great job in keeping us posted- but I am very concerned at the same time since lots of time has been passing by and we still haven't gotten a definitive answer as to if and when this stock will trade again....
Orangestar wtf??
Why all the crazy posts? Rooster is doing an incredible job at keeping us posted.
Oil
"Mirror mirror on the wall" - will this stock begin to trade again sometime this fall??
Check out IMDS 8k, excellent progress.
https://www.sec.gov/Archives/edgar/data/790652/000121390019021403/f8k102319_imagingdiag.htm
On October 23, 2019, Imaging Diagnostic Systems, Inc. ("IDSI") entered into a Consulting Agreement effective as of November 1, 2019, with Dr. Huabei Jiang to serve as IDSI’s Chief Scientific Consultant (the “Agreement”). Dr. Jiang is a Professor of Medical Engineering at the University of South Florida and a fellow of the American Institute for Medical and Biological Engineering, the International Optical Society and the Optical Society of America. He is an expert in optical tomography imaging and has made significant contributions to improvements in the final diagnosis and cure of breast cancer.
Pursuant to the Agreement, Dr. Jiang will focus on improving the technical performance and image quality of IDSI’s Computed Tomography Laser Mammography (CTLM®) breast imaging device.
The Agreement is for a term of three years, subject to satisfactory completion within one year of the Consultant’s Initial Project relating to improvement of the CTLM®’s image display resolution and accuracy. As compensation for his services, Dr. Jiang will receive $500,000 for satisfactory and timely completion of the Initial Project and $500,000 per year for two years thereafter based on satisfactory completion of work and projects to be approved by IDSI. In connection with the Agreement, IDSI issued to Dr. Jiang a nonqualified option to purchase 2,000,000 shares of its common stock at a price of $.51 per share. One-fourth of the option (500,000 shares) vested upon execution of the Agreement, and the balance of the option will vest 500,000 shares per year on the first three anniversaries of the Agreement. The option expires five years from the date of grant.
IDSI believes that the Agreement with Dr. Jiang and the expected improvement of the CTLM®’S image quality by Dr. Jiang will materially benefit IDSI by (i) enhancing marketing and sales of the CTLM® in China, (ii) better enabling the application of the CTLM® in the field of neoadjuvant therapy and (iii) leading to development of multi-modal products in the future for accurate and early detection of breast cancer. Nonetheless, there can be no assurance that Dr. Jiang’s efforts will be successful.
What is happening!!!!!!?????....- is this going to trade again!!!!!?????.......